Stifel analyst Andreas Heine upgrades Linde (NYSE:LIN) from Hold to Buy.
Expert Ratings for Arcus Biosciences
Arcus Biosciences (NYSE:RCUS) has observed the following analyst ratings within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat…